A single oral dose method for predicting steady state theophylline concentrations in clinical practice

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Respiratory Medicine

Background:

• Theophylline is a crucial medication for managing obstructive lung disease.
• Accurate theophylline dosing is essential to achieve therapeutic concentrations while minimizing toxicity.
• Traditional methods for determining optimal theophylline dosage can be time-consuming and may require multiple measurements.

Purpose of the Study:

• To compare a single-point, single-dose method for predicting oral theophylline dosage with a non-invasive approach.
• To evaluate the accuracy and precision of using a morning test dose to establish maintenance theophylline therapy.
• To assess the efficacy of different theophylline pharmacokinetic modeling methods.

Main Methods:

• Twenty patients with obstructive lung disease received an oral dose of micro-crystalline theophylline (6 mg kg-1).
• Plasma theophylline concentrations were measured 8-10 hours post-dose to calculate the optimal maintenance dose.
• Predictions from a morning test dose and an assumed clearance method were compared to observed steady-state concentrations.

Main Results:

• The morning test dose method showed a non-significant mean difference of -0.11 mumol l-1 between predicted and observed plasma theophylline concentrations.
• The assumed clearance method yielded a larger, though still non-significant, difference of -7.4 mumol l-1.
• An evening test dose resulted in a significant difference (-24.8 mumol l-1), indicating lower accuracy.

Conclusions:

• A morning test dose with a single blood sample is a precise and effective method for quickly establishing theophylline maintenance therapy in selected patients.
• This single-point method offers a safe and efficient alternative to more complex or time-consuming dosing strategies.
• The study highlights the utility of targeted pharmacokinetic assessments for optimizing drug therapy in respiratory conditions.